核桃灸结合辨证施护对糖尿病视网膜病变增殖期患者的作用探讨

doi:10.3760/cma.j.issn.1007-1245.2024.21.011

摘要/Abstract

摘要：

目的　探讨核桃灸结合辨证施护在糖尿病视网膜病变（DR）增殖期的干预作用。方法　采用前瞻性随机对照试验，选取2022年1月至2023年12月在济南市第二人民医院中医眼科就诊的184例DR增殖期患者作为研究对象，采用随机数字表法分为对照组、辨证施护组、核桃灸组、辨证施护+核桃灸组，每组46例。对照组男28例、女18例，年龄（52.19±8.06）岁，糖尿病病程（6.92±1.15）年，DR增殖期病程（8.22±1.30）个月，予以常规护理；辨证施护组男25例、女21例，年龄（55.09±9.22）岁，糖尿病病程（6.69±1.08）年，DR增殖期病程（8.41±1.36）个月，在对照组基础上予以辩证施护护理；核桃灸组男27例、女19例，年龄（53.37±10.14）岁，糖尿病病程（7.13±1.28）年，DR增殖期病程（8.70±1.42）个月，在对照组基础上予以核桃灸护理；辨证施护+核桃灸组男28例、女18例，年龄（53.95±9.16）岁，糖尿病病程（6.85±1.20）年，DR增殖期病程（8.59±1.44）个月，在对照组基础上予以辩证施护和核桃灸联合护理，各组均连续干预3个月。对比两组患者干预效果，干预前后最佳矫正视力（BCVA）、视敏度（MS）、黄斑中心凹厚度（cMT）、焦虑水平［采用焦虑自评量表（SAS）评估］、生活质量［采用中文版低视力者生活质量量表（CLVQOL）评估］及并发症发生情况。采用单因素方差分析、t检验、χ²检验、确切概率法检验、秩和检验。结果　辨证施护+核桃灸组总有效率高于辨证施护组、核桃灸组、对照组［95.56%（43/45）比80.43%（37/46）、81.40%（35/43）、61.36%（27/44）］，差异有统计学意义（P<0.05）。干预前，各组患者BCVA、MS、cMT及SAS、CLVQOL评分比较，差异均无统计学意义（均P>0.05）。干预后，辨证施护+核桃灸组BCVA、MS及CLVQOL评分均高于辨证施护组、核桃灸组、对照组［（0.69±0.11）比（0.52±0.10）、（0.50±0.08）、（0.36±0.06），（22.90±3.95）dB比（19.78±3.76）dB、（20.04±3.53）dB、（17.22±3.14）dB，（85.53±14.65）分比（73.11±12.50）分、（69.39±11.72）分、（60.48±10.26）分］，cMT及SAS评分均低于辨证施护组、核桃灸组、对照组［（229.17±29.96）μm比（339.05±52.27）μm、（354.92±56.43）μm、（434.11±63.89）μm，（30.59±5.15）分比（36.65±5.77）分、（37.83±5.62）分、（40.91±6.08）分］，差异均有统计学意义（均P<0.05）。辨证施护+核桃灸组患者并发症发生率低于辨证施护组、核桃灸组、对照组［4.44%（2/45）比17.39%（8/46）、20.93%（9/43）、25.00%（11/44）］，差异有统计学意义（P<0.05）。结论　核桃灸结合辨证施护可有效改善DR增殖期患者干预效果及视力水平，缓解焦虑情绪，提高生活质量，降低并发症发生率。

关键词:

糖尿病视网膜病变, 核桃灸, 辨证施护, 增殖期

Abstract:

Objective　To investigate the effect of walnut moxibustion combined with syndrome differentiation nursing care for patients with diabetic retinopathy (DR) during proliferative stage. Methods　One hundred and eighty-four patients with DR during proliferative stage treated at Department of Traditional Chinese Medicine Ophthalmology, Jinan Second People's Hospital from January 2022 to December 2023 were selected for the randomized controlled trial, and were divided into a control group, a syndrome differentiation group, a walnut moxibustion group, and syndrome differentiation+walnut moxibustion group by the random number table method, with 46 cases in each group. There were 28 males and 18 females in the control group; they were (52.19±8.06) years old; their diabetic course was (6.92±1.15) years; their DR course was (8.22±1.30) years. There were 25 males and 21 females in the syndrome differentiation group; they were (55.09±9.22) years old; their diabetic course was (6.69±1.08) years; their DR course was (8.41±1.36) years. There were 27 males and 19 females in the walnut moxibustion group; they were (53.37±10.14) years old; their diabetic course was (7.13±1.28) years; their DR course was (8.70±1.42) years. There were 28 males and 18 females in the syndrome differentiation+walnut moxibustion group; they were (53.95±9.16) years old; their diabetic course was (6.85±1.20) years; their DR course was (8.59±1.44) years. All the 4 groups took routine care; in addition, the syndrome differentiation group took syndrome differentiation nursing care, the walnut moxibustion group took walnut moxibustion, and the syndrome differentiation+walnut moxibustion group took syndrome differentiation nursing care and walnut moxibustion, for 3 months. The intervention effects, best corrected visual acuity (BCVA), visual acuities (MS), central macular thicknesses (cMT), anxiety levels [Self-rating Anxiety Scale (SAS)], and quality of life [Chinese-version Low Vision Quality of Life Questionnaire (CLVQOL)] before and after the intervention, and incidences of complications were compared between the two groups by one-way ANOVA, t test, χ² test, Fisher exact test, and rank sum test. Results　The total effective rate in the syndrome differentiation+walnut moxibustion group was higher than those in the syndrome differentiation group, walnut moxibustion group, and control group [95.56% (43/45) vs. 80.43% (37/46), 81.40% (35/43), and 61.36% (27/44)], with a statistical difference (P<0.05). Before the intervention, there were no statistical differences in BCVA, MS, cMT, and scores of SAS and CLVQOL between the four groups (all P>0.05). After the intervention, the BCVA, MS, and score of CLVQOL in the syndrome differentiation+walnut moxibustion group were higher than those in the syndrome differentiation group, walnut moxibustion group, and control group [(0.69±0.11) vs. (0.52±0.10), (0.50±0.08), and (0.36±0.06); (22.90±3.95) dB vs. (19.78±3.76) dB, (20.04±3.53) dB, and (17.22±3.14) dB; (85.53±14.65) vs. (73.11±12.50), (69.39±11.72), and (60.48±10.26)]; the cMT and score of SAS in the syndrome differentiation+walnut moxibustion group were lower than those in the syndrome differentiation group, walnut moxibustion group, and control group [(229.17±29.96) μm vs. (339.05±52.27) μm, (354.92±56.43) μm, and (434.11±63.89) μm; (30.59±5.15) vs. (36.65±5.77), (37.83±5.62), and (40.91±6.08)]; there were statistical differences (all P<0.05). The incidence of complications in the syndrome differentiation+walnut moxibustion group was lower than those in the syndrome differentiation group, walnut moxibustion group, and control group [4.44% (2/45) vs. 17.39% (8/46), 20.93% (9/43), and 25.00% (11/44)], with a statistical difference (P<0.05). Conclusion　Walnut moxibustion combined with syndrome differentiation nursing care can effectively improve the intervention effect and vision level of patients with DR during proliferative stage, relieve their anxiety, improve their quality of life, and reduce the incidence of complications.

Key words:

Diabetic retinopathy, Walnut moxibustion, Syndrome differentiation nursing care, Proliferative stage

王俊杰吴敏杨奕.

核桃灸结合辨证施护对糖尿病视网膜病变增殖期患者的作用探讨 [J]. 国际医药卫生导报, 2024, 30(21): 3574-3579.

Wang Junjie, Wu Min, Yang Yi.

Walnut moxibustion combined with syndrome differentiation nursing care for patients with diabetic retinopathy during proliferative stage [J]. International Medicine and Health Guidance News, 2024, 30(21): 3574-3579.

参考文献

[1] Zhou J, Chen B. Retinal cell damage in diabetic retinopathy[J].Cells,2023,12(9):1342.DOI:10.3390/cells12091342.
[2] Teo ZL, Tham YC, Yu M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis[J].Ophthalmology,2021,128(11):1580-1591.DOI:10.1016/j.ophtha.2021. 04.027.
[3] 刘妮,谢文丽. 整体护理方案对糖尿病视网膜病变患者玻璃体切除术后遵医行为及患者生活质量的影响[J]. 贵州医药,2022,46(10):1655-1656.DOI:10.3969/j.issn.1000- 744X. 2022.10.083.
[4] 曹维娜,许海莺,冯飞艳,等. 陕西省人民医院2型糖尿病患者中医临床证型分布特点及辨证施护效果分析[J]. 中医药导报,2022,28(2):91-95.DOI:10.13862/j.cnki.cn43-1446/r.2022.02.032.
[5] 王慧敏. 润目汤联合隔核桃灸治疗肝肾阴虚型干眼的临床疗效观察[D]. 济南:山东中医药大学,2021.
[6] 石小玲. 隔核桃灸治疗暴露性结膜炎60例[J]. 辽宁中医药大学学报,2009,11(2):112.DOI:10.13194/j.jlunivtcm. 2009.02.114.shixl.046.
[7] 中华医学会糖尿病学分会视网膜病变学组. 糖尿病相关眼病防治多学科中国专家共识(2021年版)[J]. 中华糖尿病杂志,2021,13(11):1026-1042.DOI:10.3760/cma.j.cn115791-20211006-00534.
[8] Zung WW. A rating instrument for anxiety disorders[J].Psychosomatics,1971,12(6):371-379.DOI:10.1016/S0033-3182(71)71479-0.
[9] 邹海东,张晳,许迅,等. 低视力者生活质量量表中文版的研制和信度与效度考评[J]. 中华眼科杂志,2005,41(3):246-251.DOI:10.3760/j:issn:0412-4081.2005.03.013.
[10] Chaudhary S, Zaveri J, Becker N. Proliferative diabetic retinopathy (PDR)[J].Dis Mon,2021,67(5):101140.DOI:10.1016/j.disamonth.2021.101140.
[11] Wufuer A, Ma J, Ainiwa P, et al. Influence of continuous 4C nursing on quality of life and self-care ability of patients with diabetes retinopathy: an observational study[J].Medicine (Baltimore),2024,103(20):e37920.DOI:10.1097/MD.0000000000037920.
[12] 段莹莹,安学冬,张月红,等. 基于络病学说从"虚气留滞"理论浅析糖尿病性视网膜病变的病机发展与治疗思路[J]. 吉林中医药,2023,43(5):501-505.DOI:10.13463/j.cnki.jlzyy.2023.05.002.
[13] Lee SS, Lingham G, Alonso-Caneiro D, et al. Macular thickness profile and its association with best-corrected visual acuity in healthy young adults[J].Transl Vis Sci Technol,2021,10(3):8.DOI:10.1167/tvst.10.3.8.
[14] Kanda S, Zhou HP, Inoue T, et al. Predicting retinal sensitivity using optical coherence tomography parameters in central serous chorioretinopathy[J].Graefes Arch Clin Exp Ophthalmol,2022,260(11):3499-3504.DOI:10.1007/s00417-022-05717-3.
[15] Pokhrel U, Pradhan E, Thakuri RS, et al. Comparison of central macular thickness between diabetic patients without clinical retinopathy and non-diabetic patients[J].Nepal J Ophthalmol,2022,14(28):41-48.DOI:10.3126/nepjoph.v14i2.40259.
[16] Puell MC, Hurtado-Ceña FJ, Pérez-Carrasco MJ, et al. Association between central retinal thickness and low luminance visual acuity in early age-related macular degeneration[J].Eur J Ophthalmol,2021,31(5):2467-2473.DOI:10.1177/1120672120968740.
[17] 刘丹,许华,孙宇轩,等. 核桃灸联合羟苯磺酸钙治疗肝肾阴虚型非增殖期糖尿病视网膜病变[J]. 中医学报,2023,38(12):2670-2677.DOI:10.16368/j.issn.1674-8999. 2023.12.425.
[18] 吴尚先. 理瀹骈文[M]. 北京:中国医药科技出版社,2011:109-122.
[19] 付伟伟,张国亮,刘志顺,等. 核桃壳眼镜灸改善干眼症状随机对照试验[J]. 中国针灸,2018,38(11):1177-1182.DOI:10.13703/j.0255-2930.2018.11.012.
[20] 唐敏,岳丽菁,王霜玲,等. 中药熏蒸联合艾灸治疗近视的临床研究[J]. 中国中医眼科杂志,2013,23(3):207-209.DOI:10.13444/j.cnki.zgzyykzz.003148.
[21] 倪孝渊,陈力为,唐佳瑶,等. 隔物核桃灸联合头面部推拿治疗儿童轻中度单纯性近视39例[J]. 中国针灸,2023,43(11):1266-1268.DOI:10.13703/j.0255-2930.20230510-k0010.
[22] 范雪燕. 核桃灸联合穴位按摩辅治干眼症临床观察[J]. 实用中医药杂志,2021,37(1):44-45.
[23] 陈记瑶,胡幼平,兰蕾,等. 眼针加核桃灸治疗睑弦赤烂案1例[J]. 中国中西医结合杂志,2023,43(7):880-881.DOI:10.7661/j.cjim.20230425.072.
[24] 王满华,张韬,张永刚. 化瘀复明汤联合羟苯磺酸钙治疗糖尿病视网膜病变患者的疗效观察[J]. 国际医药卫生导报,2024,30(7):1136-1141.DOI:10.3760/cma.j.issn. 1007-1245.2024.07.016.